In addition, comparable results are being measured in another study evaluating escalation doses of CAR T cells designed to target the prostate‐specific membrane antigen (PSMA), a cell surface antigen found on prostate cells along with other epithelial surfaces and plays a vital role in prostate cancer (NCT04249947). Here, FOLH1 is linked to prostate carcinoma.